Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1999-1-21
|
pubmed:abstractText |
A nonaromatic, small-molecule, gadolinium(3+)-chelate code named MP-2269 was synthesized and evaluated in animals as a potential MR contrast agent for blood pool. The ligand of MP-2269 was prepared by conjugating a lipophilic, albumin-binding moiety, 4-pentylbicyclo[2.2.2]octane-1-carboxylic acid, to an amino-functionalized DTPA derivative by means of a diaspartic acid linker. Proton relaxometry studies in vitro yielded spin-lattice relaxivities (R1) for MP-2269 of 6.2, 20.0 and 26.1 mM(-1)sec(-1) in water, rabbit blood, and human blood, respectively. The enhanced relaxivities in blood indicate significant binding of the agent to blood proteins. At a dose of 45 micromol/kg, MP-2269 showed a biphasic rabbit blood clearance profile with half-lives of 4.7 and 142 minutes, respectively, for the fast and slow components. In rats, the agent is cleared predominantly through the hepatobiliary pathway (approximately 70% in 24 h by this mode). The LD50 value of MP-2269 is approximately 3.0 mmol/kg in mice. Preliminary MR angiograms obtained in the rabbit showed excellent enhancement of blood vessels. Hence, MP-2269 has potential for future exploitation as a contrast agent for MR angiography.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0740-3194
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
733-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9797157-Animals,
pubmed-meshheading:9797157-Contrast Media,
pubmed-meshheading:9797157-Evaluation Studies as Topic,
pubmed-meshheading:9797157-Gadolinium DTPA,
pubmed-meshheading:9797157-Humans,
pubmed-meshheading:9797157-Lethal Dose 50,
pubmed-meshheading:9797157-Magnetic Resonance Angiography,
pubmed-meshheading:9797157-Mice,
pubmed-meshheading:9797157-Rabbits,
pubmed-meshheading:9797157-Rats,
pubmed-meshheading:9797157-Sensitivity and Specificity,
pubmed-meshheading:9797157-Tissue Distribution
|
pubmed:year |
1998
|
pubmed:articleTitle |
Synthesis and preliminary evaluation of MP-2269: a novel, nonaromatic small-molecule blood-pool MR contrast agent.
|
pubmed:affiliation |
Imaging Division, Mallinckrodt, Inc., St. Louis, Missouri 63134, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|